F

BIOPHARMA CREDIT DL -01 (B3P)

BIOPHARMA CREDIT DL -01 (B3P) is listed on F. As of 2026-03-28, reported P/E ratio is 18.00, net margin is 79.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for B3P

P/E ratio

18.00

Gross profit (TTM)

$154.66M

Net margin

79.6%

BIOPHARMA CREDIT DL -01 (B3P) — FAQ

What is B3P's P/E ratio?

The price-to-earnings (P/E) ratio for BIOPHARMA CREDIT DL -01 (B3P) is 18.00 (data as of 2026-03-28).

Does BIOPHARMA CREDIT DL -01 pay a dividend?

Dividend yield is not available in the current snapshot for BIOPHARMA CREDIT DL -01 (B3P). Check the MyAverix Finance app for the latest dividend data.

What exchange is B3P listed on?

B3P is listed on F.

What is BIOPHARMA CREDIT DL -01's net margin?

BIOPHARMA CREDIT DL -01 (B3P) reports a net margin of 79.6% (data as of 2026-03-28).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.